BRITTANY SENFF: Open Payments
NPI 1346641909 · CAMARILLO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 37 payments from 9 companies in 2025. Trend: 2023 $656 · 2024 $749 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $154 |
| Novo Nordisk Inc | 5 | $113 |
| Novartis Pharmaceuticals Corporation | 3 | $102 |
| ABBVIE INC. | 4 | $91 |
| Lundbeck LLC | 4 | $74 |
| Lilly USA, LLC | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: LEQVIO, OTEZLA, Ozempic, REXULTI, VRAYLAR, Repatha, MOUNJARO, QULIPTA.
Industry payments across CA — which companies pay providers there.
